Skip to main content

Table 1 Migration. Effects of abciximab (0.0002, 0.002, 0.02, 0.2, 2.0, and 20.0 μg/ml) on migration of HCMSMC (48 h) in comparison to untreated controls, C = controls

From: Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio

Migration (%) HCMSMC
C 100
0,0002 μg/ml Abciximab 136,29 ± 8,66
0,002 μg/ml Abciximab 136,68 ± 2,97
0,02 μg/ml Abciximab 132,43 ± 10,01
0,2 μg/ml Abciximab 120,37 ± 6,01
2 μg/ml Abciximab 110,81 ± 10,0
20 μg/ml Abciximab 98,17 ± 13,23